Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine

Cancer Statistics, 2010

Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596 · see citing works

CD44: From adhesion molecules to signalling regulators

Ponta, H., Sherman, L. S., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,393 · see citing works

World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015

McGuire, S. (2016) · Advances in Nutrition · doi:10.3945/an.116.012211 · Cited by 1,900 · see citing works

Molecular Definition of Breast Tumor Heterogeneity

Shipitsin, M. V., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,358 · see citing works

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

Zöller, M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3023 · Cited by 1,121 · see citing works

Functions of hyaluronan in wound repair

Chen, W. Y. J., & Abatangelo, G. (1999) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1999.00079.x · Cited by 1,089 · see citing works

Hyaluronic acid: A key molecule in skin aging

Papakonstantinou, E., Roth, M., & Karakiulakis, G. (2012) · Dermato-Endocrinology · doi:10.4161/derm.21923 · Cited by 1,031 · see citing works

Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway

Qian, Z., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,021 · see citing works

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Screaton, G. R., Bell, M. V., Jackson, D. G., Cornélis, F., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,016 · see citing works

Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications

Kogan, G., Šoltés, L., Stern, R., & Gemeiner, P. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9219-z · Cited by 999 · see citing works

Hyaluronic acid (hyaluronan): A review

Necas, J., Bartosikova, L., Brauner, P., & Kolar, J. (2008) · Veterinární medicína · doi:10.17221/1930-vetmed · Cited by 998 · see citing works

Folate-mediated delivery of macromolecular anticancer therapeutic agents

Lu, Y. J., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 942 · see citing works

High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat

Tian, X., Azpurua, J., Hine, C., Vaidya, A. M., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V. A., & Seluanov, A. (2013) · Nature · doi:10.1038/nature12234 · Cited by 786 · see citing works

Graphene in Biomedicine: Opportunities and Challenges

Feng, L., & Liu, Z. (2011) · Nanomedicine · doi:10.2217/nnm.10.158 · Cited by 716 · see citing works

Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications

Schanté, C. E., Zuber, G., Herlin, C., & Vandamme, T. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.03.019 · Cited by 710 · see citing works

Resolution of Lung Inflammation by CD44

Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L. E., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 676 · see citing works

Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics

Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625 · see citing works

The six hyaluronidase-like genes in the human and mouse genomes

Csoka, A. B., Frost, G. I., & Stern, R. (2001) · Matrix Biology · doi:10.1016/s0945-053x(01)00172-x · Cited by 590 · see citing works

Self-assembled hyaluronic acid nanoparticles for active tumor targeting

Choi, K. Y., Chung, H., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.030 · Cited by 580 · see citing works

Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro

Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 575 · see citing works

Hyaluronan-binding Proteins: Tying Up the Giant

Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567 · see citing works

Folate-targeted chemotherapy

Leamon, C. P. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.008 · Cited by 559 · see citing works

Hyaluronan–CD44 interactions as potential targets for cancer therapy

Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494 · see citing works

Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel

Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., Zhu, Q., Waddad, A. Y., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.022 · Cited by 468 · see citing works

CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604242 · Cited by 440 · see citing works

Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression

Sherman, L. S., Sleeman, J. P., Herrlich, P. A., & Ponta, H. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90100-7 · Cited by 431 · see citing works

Hyaluronan and its binding proteins, the hyaladherins

Toole, B. P. (1990) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(90)90081-o · Cited by 428 · see citing works

Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives

Prestwich, G. D., Marecak, D. M., Marecek, J. F., Vercruysse, K. P., & Ziebell, M. R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00242-3 · Cited by 423 · see citing works

Hyaluronic acid: the scientific and clinical evidence

Price, R. D., Berry, M. G., & Navsaria, H. A. (2007) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2007.03.005 · Cited by 413 · see citing works

The science of hyaluronic acid dermal fillers

Tezel, A., & Fredrickson, G. H. (2008) · Journal of Cosmetic and Laser Therapy · doi:10.1080/14764170701774901 · Cited by 405 · see citing works

Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer

Lee, R. J., & Huang, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8481 · Cited by 400 · see citing works

Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury

Sanchez, M. B. H., Bussolati, B., Bruno, S., Morando, L., Mauriello-Romanazzi, G., Sanavio, F., Stamenkovic, I., Biancone, L., & Camussi, G. (2007) · Kidney International · doi:10.1038/sj.ki.5002334 · Cited by 378 · see citing works

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors

Ganesh, S., Iyer, A. K., Morrissey, D. V., & Amiji, M. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.077 · Cited by 361 · see citing works

Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery

Jiang, T., Zhang, Z.-H., Zhang, Y., Lv, H., Zhou, J., Li, C., Hou, L., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.027 · Cited by 361 · see citing works

Role of integrated cancer nanomedicine in overcoming drug resistance

Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343 · see citing works

Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells

Yu, M., Jambhrunkar, S., Thorn, P., Chen, J., Gu, W., & Yu, C. (2012) · Nanoscale · doi:10.1039/c2nr32145a · Cited by 336 · see citing works

Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit

Fraser, J., Laurent, T. C., Pertoft, H., & Baxter, E. (1981) · Biochemical Journal · doi:10.1042/bj2000415 · Cited by 333 · see citing works

Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330 · see citing works

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Tijink, B. M., Buter, J., de Bree, R., Giaccone, G., Lang, M. S., Staab, A., Leemans, C. R., & van Dongen, G. A. M. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0910 · Cited by 315 · see citing works

Synthesis and Selective Cytotoxicity of a Hyaluronic Acid−Antitumor Bioconjugate

Luo, Y., & Prestwich, G. D. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9900338 · Cited by 306 · see citing works

Hyaluronan in human malignancies

Sironen, R. K., Tammi, M., Tammi, R., Auvinen, P., Anttila, M. A., & Kosma, V.-M. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.017 · Cited by 294 · see citing works

Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer

Selvaggi, G., Novello, S., Torri, V., Leonardo, E., Giuli, P. D., Borasio, P., Mossetti, C., Ardissone, F., Lausi, P. O., & Scagliotti, G. V. (2003) · Annals of Oncology · doi:10.1093/annonc/mdh011 · Cited by 293 · see citing works

Role, Metabolism, Chemical Modifications and Applications of Hyaluronan

Volpi, N., Schiller, J., Stern, R., & Šoltés, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186138 · Cited by 279 · see citing works

Understanding the Dual Nature of CD44 in Breast Cancer Progression

Louderbough, J. M., & Schroeder, J. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0156 · Cited by 274 · see citing works

Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution

Choi, K. Y., Min, K. H., Na, J. H., Choi, K., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b900456d · Cited by 272 · see citing works

CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome

Idowu, M. O., Kmieciak, M., Dumur, C. I., et al. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.05.005 · Cited by 267 · see citing works

CD44-mediated uptake and degradation of hyaluronan

Knudson, W., Chow, G., & Knudson, C. B. (2002) · Matrix Biology · doi:10.1016/s0945-053x(01)00186-x · Cited by 258 · see citing works

Target Delivery and Cell Imaging Using Hyaluronic Acid-Functionalized Graphene Quantum Dots

Al‐Nahain, A., Lee, J., In, I., Lee, H., Lee, K. D., Jeong, J. H., & Park, S. Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400219u · Cited by 258 · see citing works

Cancer Stem–like Cell Marker CD44 Promotes Bone Metastases by Enhancing Tumorigenicity, Cell Motility, and Hyaluronan Production

Hiraga, T., Ito, S., & Nakamura, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3801 · Cited by 227 · see citing works

Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look

Whatcott, C. J., Han, H., Posner, R. G., Hostetter, G. H., & Hoff, D. D. V. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0136 · Cited by 224 · see citing works

Molecular Identification of a Putative Human Hyaluronan Synthase

Watanabe, K., & Yamaguchi, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.22945 · Cited by 205 · see citing works

Binding of hyaluronate to the surface of cultured cells.

Underhill, C. B., & Toole, B. P. (1979) · The Journal of Cell Biology · doi:10.1083/jcb.82.2.475 · Cited by 202 · see citing works

Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells

Alshaer, W., Hillaireau, H., Vergnaud, J., Ismail, S. I., & Fattal, E. (2014) · Bioconjugate Chemistry · doi:10.1021/bc5004313 · Cited by 200 · see citing works

Hyaluronic Acid-Decorated Graphene Oxide Nanohybrids as Nanocarriers for Targeted and pH-Responsive Anticancer Drug Delivery

Song, E., Han, W., Li, C., et al. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am502423r · Cited by 199 · see citing works

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

Riechelmann, H., Sauter, A., Golze, W., Hanft, G., Schroen, C., Hoermann, K., Erhardt, T., & Gronau, S. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2007.10.009 · Cited by 198 · see citing works

Regulation of alternative splicing of CD44 in cancer

Procházka, L., Tesařı́k, R., & Tuřánek, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.011 · Cited by 196 · see citing works

CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma

Wang, L., Su, W., Liu, Z., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.067 · Cited by 194 · see citing works

Bioresponsive Hyaluronic Acid‐Capped Mesoporous Silica Nanoparticles for Targeted Drug Delivery

Chen, Z., Li, Z., Lin, Y., Yin, M., Ren, J., & Qu, X. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201202038 · Cited by 180 · see citing works

Nanodelivery Strategies in Cancer Chemotherapy: Biological Rationale and Pharmaceutical Perspectives

Mattheolabakis, G., Rigas, B., & Constantinides, P. P. (2012) · Nanomedicine · doi:10.2217/nnm.12.128 · Cited by 177 · see citing works

Hyaluronic acid-conjugated graphene oxide/photosensitizer nanohybrids for cancer targeted photodynamic therapy

Li, F., Park, S., Ling, D., et al. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb00506b · Cited by 175 · see citing works

Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments

Dawidczyk, C. M., Russell, L. M., & Searson, P. C. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00069 · Cited by 165 · see citing works

Expression of CD44 in human lung tumors

Penno, M. B. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)92213-6 · Cited by 164 · see citing works

Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: Comparison between invasive and non‐invasive areas

Bertrand, P., Girard, N., Delpech, B., Duval, C., d'Anjou, J., & Dauce, J. P. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520102 · Cited by 160 · see citing works

Lipoplexes Targeting the CD44 Hyaluronic Acid Receptor for Efficient Transfection of Breast Cancer Cells

Surace, C., Arpicco, S., Dufaÿ-Wojcicki, A., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800215d · Cited by 160 · see citing works

MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer

Yang, X., lyer, A., Singh, A., Choy, E., Hornicek, F. J., Amiji, M. M., & Duan, Z. (2015) · Scientific Reports · doi:10.1038/srep08509 · Cited by 159 · see citing works

Cytotoxicity of momordin-folate conjugates in cultured human cells.

Leamon, C. P., & Low, P. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)73992-1 · Cited by 142 · see citing works

In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles

Ganesh, S., Iyer, A. K., Gattacceca, F., Morrissey, D. V., & Amiji, M. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.016 · Cited by 142 · see citing works

Hyaluronan: Towards novel anti-cancer therapeutics

Karbownik, M. S., & Nowak, J. Z. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71465-8 · Cited by 142 · see citing works

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

Ganesh, S., Iyer, A. K., Weiler, J., Morrissey, D. V., & Amiji, M. M. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.29 · Cited by 134 · see citing works

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

Hao, J., Chen, H., Madigan, M. C., Cozzi, P. J., Beretov, J., Xiao, W., Delprado, W., Russell, P. J., & Li, Y. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605839 · Cited by 119 · see citing works

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

Börjesson, P. K. E., Postema, E. J., Roos, J. C., Colnot, D. R., Marres, H. A. M., van Schie, M. H., Stehle, G., de Bree, R., Snow, G. B., Oyen, W. J. G., et al. (2003) · PubMed · Cited by 113 · see citing works

Chromosomal Localization of the Human and Mouse Hyaluronan Synthase Genes

Spicer, A. P., Seldin, M. F., Olsen, A. S., Brown, N., Wells, D. E., Doggett, N. A., Itano, N., Kimata, K., Inazawa, J., & McDonald, J. A. (1997) · Genomics · doi:10.1006/geno.1997.4696 · Cited by 108 · see citing works

Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells

Föger, N., Marhaba, R., & Zöller, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.6.1169 · Cited by 108 · see citing works

Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guérin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study

Bassi, P. F., Volpe, A., D’Agostino, D., et al. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.09.073 · Cited by 104 · see citing works

Selective Targeting of Malignant Cells with Cytotoxin-Folate Conjugates

Leamon, C. P., & Low, P. S. (1994) · Journal of drug targeting · doi:10.3109/10611869409015898 · Cited by 101 · see citing works

A Requirement for the CD44 Cytoplasmic Domain for Hyaluronan Binding, Pericellular Matrix Assembly, and Receptor-mediated Endocytosis in COS-7 Cells

Jiang, H. N., Peterson, R. S., Wang, W., Bartnik, E., Knudson, C. B., & Knudson, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108654200 · Cited by 99 · see citing works

Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study

Rupp, U., Schoendorf-Holland, E., Eichbaum, M. H. R., Schütz, F., Lauschner, I., Schmidt, P., Staab, A., Hanft, G., Huober, J., Sinn, H., et al. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32801403f4 · Cited by 99 · see citing works

The Use of Amino Acid Linkers in the Conjugation of Paclitaxel with Hyaluronic Acid as Drug Delivery System: Synthesis, Self-Assembled Property, Drug Release, and In Vitro Efficiency

Xin, D., Wang, Y., & Xiang, J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9997-9 · Cited by 95 · see citing works

Hyaluronic acid-conjugated mesoporous silica nanoparticles: excellent colloidal dispersity in physiological fluids and targeting efficacy

Ma, M., Chen, H., Chen, Y., Zhang, K., Wang, X., Cui, X., & Shi, J. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm15489g · Cited by 93 · see citing works

A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity

Banzato, A., Bobisse, S., Rondina, M. B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2019 · Cited by 92 · see citing works

CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy

Baumann, M. A., & Krause, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2244 · Cited by 89 · see citing works

Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer

Yang, X., Iyer, A. K., Singh, A., Milane, L. S., Choy, E., Hornicek, F. J., Amiji, M. M., & Duan, Z. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1602-1 · Cited by 89 · see citing works

The structure and regulation of hyaluronan-binding proteins

Day, A. J. (1999) · Biochemical Society Transactions · doi:10.1042/bst0270115 · Cited by 86 · see citing works

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

Colnot, D. R., Quak, J. J., Roos, J. C., et al. (2000) · PubMed · Cited by 83 · see citing works

Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.

Stroomer, J. W. G., Roos, J. C., Sproll, M., et al. (2000) · PubMed · Cited by 78 · see citing works

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

Colnot, D. R., Roos, J. C., de Bree, R., Wilhelm, A. J., Kummer, J. A., Hanft, G., Heider, K., Stehle, G., Snow, G. B., & van Dongen, G. A. M. S. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0396-5 · Cited by 72 · see citing works

CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome

Gvozdenovic, A., Arlt, M., Campanile, C., Brennecke, P., Husmann, K., Li, Y., Born, W., Muff, R., & Fuchs, B. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1817 · Cited by 70 · see citing works

Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

Hiscox, S., Baruah, B. P., Smith, C. R., Bellerby, R., Goddard, L., Jordan, N., Poghosyan, Z. P., Nicholson, R. I., Barrett-Lee, P. J., & Gee, J. M. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-458 · Cited by 70 · see citing works

CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis

Serafino, A., Zonfrillo, M., Andreola, F., et al. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795655976 · Cited by 63 · see citing works

The Effect of Anti-CD44 Monoclonal Antibodies on Differentiation and Proliferation of Human Acute Myeloid Leukemia Cells

Gadhoum, Z., Delaunay, J., Maquarre, E., et al. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819042000206687 · Cited by 61 · see citing works

Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy

Singh, A., Talekar, M., Tran, T.-H., Samanta, A., Sundaram, R., & Amiji, M. M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01083c · Cited by 60 · see citing works

Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells

Arpicco, S., Rosa, G. D., & Fattal, E. (2013) · Journal of Drug Delivery · doi:10.1155/2013/860780 · Cited by 59 · see citing works

Nano graphene oxide–hyaluronic acid conjugate for target specific cancer drug delivery

Jung, H. S., Lee, M., Kong, W. H., et al. (2014) · RSC Advances · doi:10.1039/c4ra00605d · Cited by 58 · see citing works

The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species

Jahn, M., Baynes, J., & Spiteller, G. (1999) · Carbohydrate Research · doi:10.1016/s0008-6215(99)00186-x · Cited by 58 · see citing works

Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment

Wei, H.-J., Yin, T., Zhu, Z., Shi, P.-F., Tian, Y., & Wang, C. (2011) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(11)60073-8 · Cited by 57 · see citing works

Hyaluronan, a truly “youthful” polysaccharide. Its medical applications

Robert, L. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2014.05.019 · Cited by 54 · see citing works

The prognostic value of CD44 expression in gastric cancer: A meta-Analysis

Chen, Y., Fu, Z., Xu, S., et al. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.08.001 · Cited by 54 · see citing works

Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer

Schrevel, M., Gorter, A., Kolkman-Uljee, S. M., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.239 · Cited by 53 · see citing works

Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.

de Bree, R., Roos, J. C., Quak, J. J., et al. (1995) · PubMed · Cited by 51 · see citing works

HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells

Song, G.-L., Liao, X., Zhou, L., et al. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.02.005 · Cited by 49 · see citing works

Transferrin receptors in human cancerous tissues.

Niitsu, Y., Kohgo, Y., Nishisato, T., et al. (1987) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.153.239 · Cited by 48 · see citing works

Current research on hyaluronic acid-drug bioconjugates.

Zhang, H., Huang, S.-L., Yang, X.-Y., & Zhai, G. (2014) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2014.08.067 · Cited by 47 · see citing works

Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.

Postema, E. J., Börjesson, P. K. E., Buijs, W. C. A. M., et al. (2003) · PubMed · Cited by 42 · see citing works

Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data

Bahnassy, A. A., Fawzy, M., El-Wakil, M., et al. (2014) · Translational research · doi:10.1016/j.trsl.2014.07.009 · Cited by 42 · see citing works

Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study

Wang, Z., Shi, Q., Wang, Z., Gu, Y., Shen, Y., Sun, M.-M., Deng, M., Zhang, H., Junchu, F., Zhang, S., et al. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.06.009 · Cited by 41 · see citing works

Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells

Nadella, V., Wang, Z., Johnson, T. S., Griffin, M., & Devitt, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.020 · Cited by 40 · see citing works

Paclitaxel-hyaluronan hydrosoluble bioconjugate: Mechanism of action in human bladder cancer cell lines

Montagner, I. M., Banzato, A., Zuccolotto, G., et al. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.01.005 · Cited by 38 · see citing works

Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro

Herrera‐Gayol, A., & Jothy, S. (2001) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2001.iep196.x · Cited by 36 · see citing works

Effects of hyaluronan on the invasive properties of human breast cancer cells in vitro.

Herrera‐Gayol, A., & Jothy, S. (2001) · PubMed · doi:10.1046/j.1365-2613.2001.iep0082-0193-x · Cited by 34 · see citing works

Development of a fluorescent substrate to measure hyaluronidase activity

Zhang, L.-S., & Mummert, M. E. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.04.040 · Cited by 31 · see citing works

Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.

Colnot, D. R., Ossenkoppele, G. J., Roos, J. C., Quak, J. J., de Bree, R., Börjesson, P. K. E., Huijgens, P. C., Snow, G. B., & van Dongen, G. A. M. S. (2002) · PubMed · Cited by 29 · see citing works

CD44: survival and metastasis in chondrosarcoma

Heyse, T. J., Malcherczyk, D., Moll, R., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.02.007 · Cited by 29 · see citing works

Hyaluronic acid produced by human synovial fibroblasts. Effect of polyinosinic‐polycytidylic acid (POLY I:C) and interferon

Yaron, M., Yaron, I., Smetana, O., et al. (1976) · Arthritis & Rheumatism · doi:10.1002/art.1780190612 · Cited by 27 · see citing works

Application of Collagen-Model Triple-Helical Peptide-Amphiphiles for CD44-Targeted Drug Delivery Systems

Ndinguri, M. W., Zheleznyak, A., Lauer, J. L., Anderson, C. J., & Fields, G. B. (2012) · Journal of Drug Delivery · doi:10.1155/2012/592602 · Cited by 27 · see citing works

Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis

Kiuchi, S., Ikeshita, S., Miyatake, Y., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.12.001 · Cited by 25 · see citing works

CD44 variant, but not standard CD44 isoforms, mediate disassembly of endothelial VE‐cadherin junction on metastatic melanoma cells

Zhang, P., Fu, C., Bai, H., Song, E., & Song, Y. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.10.027 · Cited by 23 · see citing works

Receptor Mediated Endocytosis and Cytotoxicity of Transferrin-Mitomycin C Conjugate in the HepG2 Cell and Primary Cultured Rat Hepatocyte.

Tanaka, T., Fujishima, Y., & Kaneo, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.268 · Cited by 18 · see citing works

Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like ATL cells in an NF-κB- and vimentin-dependent manner

Miyatake, Y., Sheehy, N., Ikeshita, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.055 · Cited by 16 · see citing works

Expression of the cell adhesion molecule CD44 in human lung tumors and cell lines*

RESNICK, N., CLARKE, M., Siegfried, J. M., et al. (1998) · Molecular Diagnosis · doi:10.1016/s1084-8592(98)80057-x · Cited by 15 · see citing works

Pharmacokinetic profile of Oncofid-S after intraperitoneal and intravenous administration in the rat

Tringali, G., Bettella, F., Greco, M. C., et al. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01417.x · Cited by 13 · see citing works

Hydrosoluble, Metabolically Fragile Bioconjugates by Coupling Tetrabutylammonium Hyaluronan with 2′ Paclitaxel-4-Bromobutyrate: Synthesis and Antitumor Properties

Capodilupo, A., Crescenzi, V., Francescangeli, A., et al. (2003) · Padua Research Archive (University of Padova) · Cited by 6 · see citing works

Conquering the Hypoxia Limitation for Photodynamic Therapy

Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705 · see citing works

Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor

Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375 · see citing works

Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells

Lv, Y., Xu, C., Zhao, X., Lin, C., Yang, X., Xin, X., Zhang, L., Qin, C., Han, X., Yang, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b08051 · Cited by 235 · see citing works

CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment

Tirella, A., Kloc-Muniak, K., Good, L., Ridden, J., Ashford, M., Puri, S., & Tirelli, N. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.032 · Cited by 60 · see citing works

Imiquimod-gemcitabine nanoparticles harness immune cells to suppress breast cancer

Singh, B., Maharjan, S., Pan, D. C., Zhao, Z., Gao, Y., Zhang, Y. S., & Mitragotri, S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121302 · Cited by 49 · see citing works

Targeting tumor extracellular matrix with nanoparticles to circumvent therapeutic resistance

Ding, X., Liang, Y., Zhou, S., Wu, Y., Sałata, P., Mikolajczk-Martinez, A., Khosrawipour, V., & Zhang, Z. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113786 · Cited by 20 · see citing works

Particle characterisation in drug delivery

Vllasaliu, D., & Singh, I. S. (2014) · Lincoln Repository (University of Lincoln) · Cited by 2 · see citing works

Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers

Raza, F., Zafar, H., You, X., Asifullah, K., Wu, J., & Ge, L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01842e · Cited by 83 · see citing works

Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases

Rao, N. V., Rho, J. G., Um, W., Ek, P. K., Nguyen, V. Q., Oh, B. H., Kim, W., & Park, J. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100931 · Cited by 78 · see citing works

Drug nanocrystals as nanocarrier-based drug delivery systems

Arti, S., Bharti, M., Kumar, V., Saruchi, S., Rehani, V., & Dhiman, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824024-3.00018-x · Cited by 8 · see citing works

Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate

Arpicco, S., Bartkowski, M., Barge, A., et al. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.578008 · Cited by 35 · see citing works